Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,745 | 143 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mentor Worldwide LLC | $631.16 | 11 | $0 (2023) |
| Incyte Corporation | $365.71 | 14 | $0 (2024) |
| Allergan, Inc. | $364.14 | 11 | $0 (2020) |
| Lilly USA, LLC | $336.26 | 22 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $278.29 | 11 | $0 (2024) |
| LEO Pharma Inc. | $163.30 | 9 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $137.40 | 4 | $0 (2024) |
| Amgen Inc. | $133.47 | 6 | $0 (2020) |
| ABBVIE INC. | $128.20 | 6 | $0 (2024) |
| Janssen Biotech, Inc. | $123.91 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,363 | 58 | Incyte Corporation ($328.69) |
| 2023 | $591.82 | 14 | Mentor Worldwide LLC ($183.50) |
| 2022 | $12.33 | 1 | Endo Pharmaceuticals Inc. ($12.33) |
| 2021 | $149.26 | 7 | Janssen Biotech, Inc. ($61.09) |
| 2020 | $194.20 | 9 | Sientra, Inc. ($53.12) |
| 2019 | $613.83 | 27 | Allergan Inc. ($190.44) |
| 2018 | $502.96 | 17 | Mentor Worldwide LLC ($245.36) |
| 2017 | $317.78 | 10 | Allergan Inc. ($110.01) |
All Payment Transactions
143 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.65 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $26.81 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.49 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Immunology | ||||||
| 11/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $6.79 | General |
| Category: Immunology | ||||||
| 10/09/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: DERMATOLOGY | ||||||
| 10/08/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $7.39 | General |
| Category: Dermatology | ||||||
| 10/02/2024 | Almirall LLC | Seysara (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Dermatology | ||||||
| 10/01/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $14.96 | General |
| Category: Dermatology | ||||||
| 09/17/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $110.71 | General |
| Category: Dermatology | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Immunology | ||||||
| 09/05/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Immunology | ||||||
| 08/29/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.68 | General |
| Category: Dermatology | ||||||
| 08/28/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Dermatology | ||||||
| 08/16/2024 | Integra LifeSciences Corporation | Integra (Device), Integra, Integra | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Recon-Skin and Wound | ||||||
| 08/15/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: Immunology | ||||||
| 08/07/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: ADALIMUMAB-BWWD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 687 | 1,095 | $119,545 | $46,872 |
| 2022 | 20 | 934 | 1,405 | $162,625 | $68,457 |
| 2021 | 16 | 796 | 1,294 | $128,508 | $54,336 |
| 2020 | 24 | 942 | 1,570 | $151,815 | $69,237 |
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 156 | 232 | $25,765 | $10,227 | 39.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 90 | 132 | $7,788 | $4,488 | 57.6% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 30 | 31 | $7,802 | $4,393 | 56.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 81 | 81 | $11,665 | $4,038 | 34.6% |
| 64721 | Release and/or relocation of hand nerve | Office | 2023 | 11 | 12 | $6,804 | $3,629 | 53.3% |
| 13152 | Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | Office | 2023 | 15 | 15 | $7,575 | $3,601 | 47.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 52 | $8,273 | $3,160 | 38.2% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 14 | 14 | $8,406 | $3,057 | 36.4% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 37 | 45 | $10,429 | $2,865 | 27.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 20 | 21 | $4,662 | $1,750 | 37.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $4,172 | $1,568 | 37.6% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 12 | 12 | $2,232 | $1,228 | 55.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 27 | 28 | $3,264 | $1,040 | 31.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 36 | 40 | $5,291 | $877.57 | 16.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 58 | 326 | $3,586 | $479.49 | 13.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 12 | $934.00 | $315.84 | 33.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 20 | 23 | $897.00 | $154.79 | 17.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 173 | 264 | $29,303 | $11,972 | 40.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 149 | 149 | $19,916 | $8,121 | 40.8% |
| 13152 | Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | Office | 2022 | 24 | 25 | $12,625 | $5,669 | 44.9% |
| 64721 | Release and/or relocation of hand nerve | Office | 2022 | 17 | 17 | $9,639 | $5,360 | 55.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 102 | 161 | $9,567 | $5,273 | 55.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 65 | 73 | $11,464 | $4,938 | 43.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 39 | 42 | $9,324 | $4,197 | 45.0% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2022 | 28 | 29 | $6,525 | $3,655 | 56.0% |
About Dr. Mychi Le, MD
Dr. Mychi Le, MD is a Plastic Surgery healthcare provider based in Overland Park, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2009. The National Provider Identifier (NPI) number assigned to this provider is 1952539660.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mychi Le, MD has received a total of $3,745 in payments from pharmaceutical and medical device companies, with $1,363 received in 2024. These payments were reported across 143 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($3,745).
As a Medicare-enrolled provider, Le has provided services to 3,359 Medicare beneficiaries, totaling 5,364 services with total Medicare billing of $238,902. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Practice Information
- Specialty Plastic Surgery
- Other Specialties Plastic Surgery
- Location Overland Park, KS
- Active Since 07/01/2009
- Last Updated 12/12/2025
- Taxonomy Code 208200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1952539660
Products in Payments
- OPZELURA (Drug) $365.71
- MemoryGel Breast Implants (Device) $313.57
- XIAFLEX (Biological) $278.29
- TALTZ (Drug) $253.58
- MENTOR MemoryGel Resterilizable Gel Sizer (Device) $183.50
- Zoryve (Drug) $137.40
- NATRELLE (Device) $133.12
- Enbrel (Biological) $120.56
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT (Device) $112.10
- LITFULO (Drug) $111.73
- BOTOX COSMETIC (Biological) $104.21
- ADBRY (Biological) $92.76
- TREMFYA (Drug) $85.53
- OLUMIANT (Drug) $82.68
- ARTOURA Breast Tissue Expander (Device) $78.63
- RINVOQ (Biological) $73.80
- ENSTILAR (Drug) $70.54
- VTAMA (Drug) $69.88
- LIBTAYO (Biological) $61.33
- SPEVIGO (Drug) $58.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Plastic Surgery Doctors in Overland Park
Dr. David Zamierowski, M.d, M.D
Plastic Surgery — Payments: $14.1M
Dr. Danny Bennett, M.d, M.D
Plastic Surgery — Payments: $6,514
Spencer Eagan, Md, MD
Plastic Surgery — Payments: $6,223
Arhana Chattopadhyay, Md, MD
Plastic Surgery — Payments: $2,455
Abbey Bays, Mpas, Pa-C, MPAS, PA-C
Plastic Surgery